Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Maartje Valkema; Bo Noordman; Bas Wijnhoven; Manon Spaander; Katharina Biermann; Sjoerd Lagarde; RJ Bennink; WMJ Schreurs; MJ Roef; MGG Hobbelink; MJR Janssen; Laura Graven; Jan van Lanschot; R. Valkema

doi:10.2967/jnumed.118.224196

Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Maartje Valkema, Bo Noordman, Bas Wijnhoven, Manon Spaander, Katharina Biermann, Sjoerd Lagarde, RJ Bennink, WMJ Schreurs, MJ Roef, MGG Hobbelink, MJR Janssen, Laura Graven, Jan van Lanschot, R. Valkema

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1553-1559
Number of pages	7
Journal	Journal of Nuclear Medicine
Volume	60
Issue number	11
DOIs	https://doi.org/10.2967/jnumed.118.224196
Publication status	Published - 2019

Research programs

EMC MM-01-40-01
EMC MM-03-24-01
EMC MM-03-47-02-A
EMC MM-04-20-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2967/jnumed.118.224196

http://hdl.handle.net/1765/120933

Cite this

Valkema, M., Noordman, B., Wijnhoven, B., Spaander, M., Biermann, K., Lagarde, S., Bennink, RJ., Schreurs, WMJ., Roef, MJ., Hobbelink, MGG., Janssen, MJR., Graven, L., van Lanschot, J., & Valkema, R. (2019). Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Journal of Nuclear Medicine, 60(11), 1553-1559. https://doi.org/10.2967/jnumed.118.224196

@article{18539220306c4407ae385589edde488a,

title = "Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer",

author = "Maartje Valkema and Bo Noordman and Bas Wijnhoven and Manon Spaander and Katharina Biermann and Sjoerd Lagarde and RJ Bennink and WMJ Schreurs and MJ Roef and MGG Hobbelink and MJR Janssen and Laura Graven and {van Lanschot}, Jan and R. Valkema",

year = "2019",

doi = "10.2967/jnumed.118.224196",

language = "Undefined/Unknown",

volume = "60",

pages = "1553--1559",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine and Molecular Imaging",

number = "11",

}

Valkema, M , Noordman, B , Wijnhoven, B , Spaander, M, Biermann, K, Lagarde, S, Bennink, RJ, Schreurs, WMJ, Roef, MJ, Hobbelink, MGG, Janssen, MJR, Graven, L, van Lanschot, J & Valkema, R 2019, 'Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer', Journal of Nuclear Medicine, vol. 60, no. 11, pp. 1553-1559. https://doi.org/10.2967/jnumed.118.224196

TY - JOUR

T1 - Accuracy of F-18-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

AU - Valkema, Maartje

AU - Noordman, Bo

AU - Wijnhoven, Bas

AU - Spaander, Manon

AU - Biermann, Katharina

AU - Lagarde, Sjoerd

AU - Bennink, RJ

AU - Schreurs, WMJ

AU - Roef, MJ

AU - Hobbelink, MGG

AU - Janssen, MJR

AU - Graven, Laura

AU - van Lanschot, Jan

AU - Valkema, R.

PY - 2019

Y1 - 2019

U2 - 10.2967/jnumed.118.224196

DO - 10.2967/jnumed.118.224196

M3 - Article

C2 - 30877177

SN - 0161-5505

VL - 60

SP - 1553

EP - 1559

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 11

ER -